| Apr 8 |
Maravai LifeSciences prices upsized secondary offering at $31.25
|
| Apr 8 |
Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders
|
| Apr 6 |
Maravai’s 1Q Revenue Outlook Misses Estimates; Street Sees Over 34% Upside
|
| Apr 6 |
Maravai LifeSciences expects Q1 revenue above consensus, prior guidance
|
| Apr 6 |
Maravai LifeSciences launches secondary offering
|
| Apr 5 |
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
|
| Apr 5 |
Maravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations Range
|
| Mar 15 |
Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services
|
| Mar 8 |
Maravai Lifesciences Holdings (MRVI) Investor Presentation - Slideshow
|
| Mar 7 |
Analysts Just Made A Dazzling Upgrade To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Forecasts
|
| Mar 3 |
Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) Q4 2020 Earnings Call Transcript
|
| Mar 3 |
Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q4 2020 Results - Earnings Call Transcript
|
| Mar 3 |
Dow Jones Futures: Stock Market Rally Falls To Key Support As Nio, Zoom, Target Dive; Vaccine Play Soars Late
|
| Mar 2 |
Maravai LifeSciences Holdings EPS beats by $0.04, beats on revenue
|
| Mar 2 |
Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance
|
| Mar 2 |
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A to Host Earnings Call
|
| Mar 2 |
Earnings Scheduled For March 2, 2021
|
| Mar 1 |
10 Best New Stocks To Buy Now
|
| Mar 1 |
Maravai LifeSciences Announces March 2021 Investor Conference Schedule
|
| Feb 22 |
Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) About To Shift From Loss To Profit
|
| Feb 10 |
Maravai LifeSciences Expands Its Intellectual Property Portfolio
|
| Feb 1 |
88 Biggest Movers From Friday
|
| Jan 28 |
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021
|
| Jan 26 |
Breakout Watch: IPO Leader, Pfizer Vaccine Partner MRVI Stock Enters Buy Zone
|
| Jan 21 |
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
|
